title: Oxidative stress in developmental brain disorders.
abstract: In order to examine the involvement of oxidative stress in developmental brain disorders, we have performed immunohistochemistry in autopsy brains and enzyme-linked immunosorbent assay (ELISA) in the cerebrospinal fluid and urines of patients. Here, we review our data on the hereditary DNA repair disorders, congenital metabolic errors and childhood-onset neurodegenerative disorders. First, in our studies on hereditary DNA repair disorders, increased oxidative DNA damage and lipid peroxidation were carried out in the degeneration of basal ganglia, intracerebral calcification and cerebellar degeneration in patients with xeroderma pigmentosum, Cockayne syndrome and ataxia-telangiectasia-like disorder, respectively. Next, congenital metabolic errors, apoptosis due to lipid peroxidation seemed to cause neuronal damage in neuronal ceroid-lipofuscinosis. Oxidative stress of DNA combined with reduced expression of antioxidant enzymes occurred in the lesion of the cerebral cortex in mucopolysaccharidoses and mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. In childhood-onset neurodegenerative disorders, increased oxidative DNA damage and lipid peroxidation may lead to motor neuron death in spinal muscular atrophy like in amyotrophic lateral sclerosis. In patients with dentatorubral-pallidoluysian atrophy, a triplet repeat disease, deposition of oxidative products of nucleosides and reduced expression of antioxidant enzymes were found in the lenticular nucleus. In contrast, the involvement of oxidative stress is not definite in patients with Lafora disease. Rett syndrome patients showed changes of oxidative stress markers and antioxidant power in urines, although the changes may be related to systemic complications.
authors.affiliation: Department of Clinical Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan. hayashi-ms@igakuken.or.jp
authors.forename: Masaharu
authors.initials: M
authors.lastname: Hayashi
authors.forename: Rie
authors.initials: R
authors.lastname: Miyata
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Tanuma
mesh_terms: D000080242:8-Hydroxy-2'-Deoxyguanosine; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000447:Aldehydes / Q000378:metabolism; D001921:Brain / Q000254:growth & development / Q000378:metabolism / Q000473:pathology; D001927:Brain Diseases / Q000235:genetics / Q000503:physiopathology* / Q000652:urine; D002648:Child; D003057:Cockayne Syndrome / Q000378:metabolism / Q000473:pathology; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000652:urine; D002658:Developmental Disabilities / Q000235:genetics / Q000503:physiopathology* / Q000652:urine; D005260:Female; D006801:Humans; D015227:Lipid Peroxidation / Q000235:genetics; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D014983:Xeroderma Pigmentosum / Q000378:metabolism / Q000473:pathology; D055815:Young Adult
chemical_list: D000447:Aldehydes; C046538:4-hydroxy-2-octenal; D000080242:8-Hydroxy-2'-Deoxyguanosine; D003849:Deoxyguanosine